Navigation Links
Single-donor Islet Transplantation Procedure Shows Promise For Patients With Type 1 Diabetes

Patients with type 1 diabetes who received islet transplantation from a single donor pancreas were insulin independent one year later, according to a study in the February 16 issue of JAMA, a theme issue on medical applications of biotechnology.

Type 1 diabetes remains a therapeutic challenge, according to background information in the article. The success rate of islet (cells that produce insulin to control blood sugar levels) transplants has recently been increased markedly by transplanting a higher number of islets prepared from 2 to 4 donor pancreases. However, for islet transplants to become a widespread clinical reality, additional advances are still needed. In particular, restoration of insulin independence must be achieved with a single donor, as is also the case with pancreas transplants, to reduce the risks and costs and increase the availability of islet transplantation.

Bernhard J. Hering, M.D., of the University of Minnesota, Minneapolis, and colleagues conducted a study to assess the effectiveness and safety of islet transplantation from a single pancreas. The trial was conducted from July 2001 to August 2003 and enrolled eight women with type 1 diabetes.

During the trial there were no serious, unexpected, or procedure- or immunosuppression-related adverse events. All eight recipients achieved insulin independence and freedom from hypoglycemia. Five remained insulin-independent for longer than 1 year.

"Our results mark a distinct advance in islet transplant efficacy. We not only achieved insulin independence using islets from only 1 donor pancreas [as compared with 2 to 4 in another trial], we also achieved superior glycemic control (as evidenced by normal results of oral glucose tolerance testing in 4 of 5 recipients with sustained insulin independence) using significantly fewer islets," the authors write. "These findings may have implications for the ongoing transition of islet transplantation from clinical investigatio n to routine clinical care."

"While these findings may suggest a distinct advance in islet transplantation, further study in a larger population with longer follow-up will be critical to assess the risk-benefit ratio of this emerging therapeutic option," the researchers conclude.


'"/>

Source:Journal Of The American Medical Association


Related biology news :

1. World-first Living Donor Islet Cell Transplant A Success; Procedure Offers Promise For Diabetics
2. First North American Encapsulated Islet Transplant without Long-term Immune Suppression into a Patient with Type 1 Diabetes
3. Transplantation Of Monkey Embryonic Stem Cells Reverses Parkinson Disease In Primates
4. Circles Of DNA Might Help Predict Success Of Stem Cell Transplantation
5. Procedure predicts embryos most likely to result in pregnancy
6. Novel Asthma Study Shows Multiple Genetic Input Required; Single-gene Solution Shot Down
7. UCLA Study Shows One-Third of Drug Ads in Medical Journals Do Not Contain References Supporting Medical Claims
8. Novel Enzyme Shows Potential As An Anti-HIV Target
9. UCSD Discovery Shows How Embryonic Stem Cells Perform Quality Control Inspections
10. Special Imaging Study Shows Failing Hearts Are Energy Starved
11. Molecular Motors Cooperate In Moving Cellular Cargo, Study Shows
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/11/2017)... 2017 NXT-ID, Inc. (NASDAQ:   NXTD ... the appointment of independent Directors Mr. Robin D. Richards ... of Directors, furthering the company,s corporate governance and expertise. ... Gino Pereira , Chief ... to their guidance and benefiting from their considerable expertise as ...
(Date:4/5/2017)... , April 5, 2017 Today ... announcing that the server component of the HYPR platform ... for providing the end-to-end security architecture that empowers biometric ... HYPR has already secured over 15 million users ... including manufacturers of connected home product suites and physical ...
(Date:4/3/2017)... April 3, 2017  Data captured by ... platform, detected a statistically significant association between ... to treatment and objective response of cancer ... to predict whether cancer patients will respond ... as well as to improve both pre-infusion potency ...
Breaking Biology News(10 mins):
(Date:7/13/2017)... , ... July 13, 2017 , ... ... accreditation in Specialty Pharmacy. URAC is the independent leader in promoting healthcare quality ... a comprehensive commitment to quality care, improved processes and better patient outcomes. ...
(Date:7/13/2017)... ... July 13, 2017 , ... FireflySci Inc. started ... Blast forward seven years and now they are home to a tremendous line ... wavelength accuracy, and resolution testing. , One mega advantage that FireflySci ...
(Date:7/13/2017)... ... July 13, 2017 , ... After 11 years ... Science Center, Christopher Laing, MRCVS, Ph.D. has been tapped to lead the effort ... will become the first Executive Director at the newly formed Capital City Innovation ...
(Date:7/13/2017)... , ... July 13, 2017 , ... Microscan , ... solutions for life sciences, will demonstrate advancements of the MicroHAWK platform for barcode reading ... from Booth #4456 at the AACC Clinical Lab Expo, taking place on August 1–3 ...
Breaking Biology Technology: